Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Puri

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cells|May 28, 2022
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung CancerChike Osude, Leo Lin, Meet Patel, et al.
Current Topics in Medicinal Chemistry|January 10, 2020
Potential Telomere-Related Pharmacological TargetsJoseph Berei, Adam Eckburg, Edward Miliavski, et al.
Cancer Biology & Therapy|June 11, 2014
Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapyDeven Etnyre, Amanda L Stone, Jason T Fong, et al.
Therapeutic Advances in Medical Oncology|September 25, 2020
EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancerZachary D Crees, Caleb Shearrow, Leo Lin, et al.
Cancers|August 12, 2022
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted TherapiesTaylor Rager, Adam Eckburg, Meet Patel, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cells|May 28, 2022
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung CancerChike Osude, Leo Lin, Meet Patel, et al.
Current Topics in Medicinal Chemistry|January 10, 2020
Potential Telomere-Related Pharmacological TargetsJoseph Berei, Adam Eckburg, Edward Miliavski, et al.
Cancer Biology & Therapy|June 11, 2014
Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapyDeven Etnyre, Amanda L Stone, Jason T Fong, et al.
Therapeutic Advances in Medical Oncology|September 25, 2020
EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancerZachary D Crees, Caleb Shearrow, Leo Lin, et al.
Cancers|August 12, 2022
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted TherapiesTaylor Rager, Adam Eckburg, Meet Patel, et al.
Pageof 4